Pharmacy benefits are broken. To find a solution, it requires we re-imagine it from the ground up with the right balance of empathy and fiscal sustainability.

Employers can adapt benefit strategies to manage the rising costs and demand of GLP-1 drugs. Learn how SmithRx helps optimize pharmacy spend while supporting member health.

Get essential 1/1 readiness tips and tricks straight from SmithRx pharmacy benefit experts.

Discover how a national union saw dramatic improvements in their member experience and reduced spend with SmithRx.

Discover why large employers are moving away from traditional PBMs and how SmithRx’s transparent model delivers sustainable savings and better service.

Discover the essentials of PBM data access and reporting—and why they’re crucial to achieving peak performance and realizing meaningful savings for your plan.

Discover how one HR leader took control of their pharmacy spend by questioning the status quo and prioritizing transparency in their partnerships.

Explore which medications fall into the ‘specialty drug’ category, how legacy and modern PBMs treat these drugs, and what a more innovative, sustainable approach to specialty drugs can look like.

Explore our key takeaways from the SmithRx BAM Summit and discover why transparency is the key to a better, brighter future for pharmacy benefits.

Dive into the science behind GLP-1s, trends and demands employers are seeing for these drugs, and how you can ensure you’ve got the right building blocks for GLP-1 success.

Walk through a comparsion of different plan options to understand why a self-insured, carve-out model is the best approach.

Discover how Spectrum cut pharmacy spend by 99% and transformed their member experience with a transparent, pass-through pharmacy benefit manager.

Get a rundown of Alan Pannier’s, SVP of Product Strategy at SmithRx, recent conversation with David Williams on the CareTalk Podcast, where he discussed precisely who is losing in legacy health’s game—and what can be done to save pharmacy benefits.

Discover how legacy Pharmacy Benefits Managers are failing the pharmacy industry and why modern PBMs are the future of pharmacy benefits.

Learn how cost-containment programs within a transparent PBM model can lower pharmacy spend and support sustainable plan value.

Changing your pharmacy benefits manager (PBM) for your self-funded plan is a major undertaking, but it doesn't have to be a source of stress. With the right partner and a clear plan, you can ensure a smooth transition that minimizes disruption for your members and delivers the best possible financial outcomes for your organization. In the first episode of our Full Disclosure series, we demystified the PBM transition experience with pharmacy experts, Alissa Johnson, Senior Director, Clinical Strategy at SmithRx, and Joy Gilbert, SVP, Customer Success at SmithRx, and broke down the core stages of implementing a new pharmacy benefits partner. Continue reading to get a complete rundown of the transition experience, as well as the things you should get from your PBM at each stage, below. This isn't a simple checklist; our experts walk through a complete roadmap to help you navigate the process with confidence, from the initial planning stages to going live and beyond.

Discover what the pillars of a modern PBM are and the effect they have on the pharmacy benefits experience.

It can be hard to determine what is real savings vs discount claims in the pharmacy industry. Learn about what to look for in PBM reporting here.

Get an analysis of our Q2 2025 results and explore how our Drug Pathways Engine is driving down costs in key Manageable Therapeutic Areas (MTAs).

Explore PBM reform: its meaning, drivers, and how emerging transparent PBMs like SmithRx deliver better outcomes.

Legacy PBMs are still failing to evolve and offer effective, patient-first healthcare—leaving employers unsatisfied. Learn more here about legacy PBMs and the future of transparency.

Self-funded health plans offer cost savings and flexibility—but only if you have the right PBM partner. Learn how employers are thriving with SmithRx’s transparent, proactive model.

Explore barriers to biosimilar adoption, such as PBM practices, regulatory limitations, and provider and patient level friction and learn what employers can do to promote uptake.

Discover how vertical integration and pricing manipulation by PBMs are limiting biosimilar access—and what employers can do to ensure savings and transparency.